Voquezna belongs to a group of drugs called potassium-competitive acid blockers ... The following table highlights the basics of Voquezna’s dosages. All doses are listed in milligrams (mg).

Exclusion criteria included therapies (such as beta-adrenoceptor blockers) that could interfere with ... Patients were converted from HC to MR-HC, with the dose of MR-HC being equivalent to the total ...

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGSNet product sales of FILSPARI ...

The dose of the first- or second-generation β ... Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring intravenous ...

Android 16 Beta 2 brings a new feature that makes it easy to change system measurement units, temperature units, and other regional settings. For a long time, Android has set default values for ...

The following table lists drugs that may interact with ... angiotensin II receptor blockers (ARBs), such as valsartan (Diovan) • beta-blockers, such as carvedilol (Coreg) can make certain ...

JAIPUR: The state govt Monday introduced the Rajasthan Prohibition of Unlawful Conversion of Religion Bill, 2025, to prevent illegal conversions by force, fraud or marriage in the state assembly.

Though the renal protection provided by antihypertensive doses of ACE inhibitors and ARBs has been extensively studied, the dose response of these agents may be different for renal protection.

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGS Net product sales of FILSPARI totaled $50 million in 4Q 2024; $132 million for full yea ...